{
    "title": "To amend titles XVIII and XIX of the Social Security Act to provide for continuity of Medicare prescription drug coverage for full-benefit dual eligible individuals, for Medicare prescription drug coverage of benzodiazepines and off-label uses of certain prescription drugs and biological products, for optional Medicaid coverage of Medicare prescription drug cost-sharing for full-benefit dual eligible individuals, for authorization to the Secretary of Health and Human Services to waive certain determinations denying Medicare prescription drug coverage, and for holding pharmacies harmless for certain costs incurred during implementation of Medicare part D.",
    "content": "SECTION 1. CONTINUITY OF MEDICARE PRESCRIPTION DRUG COVERAGE FOR FULL-\n              BENEFIT DUAL ELIGIBLE INDIVIDUALS.\n\n    (a) In General.--Section 1860D-2(a) of the Social Security Act (42 \nU.S.C. 1395w-102(a)) is amended--\n            (1) in paragraph (1), by inserting ``subject to paragraph \n        (6),'' after ``part C''; and\n            (2) by adding at the end the following new paragraph:\n            ``(6) Continuation of medicare coverage for certain \n        prescriptions for full-benefit dual eligible individuals.--In \n        the case of an individual who, as of the date the individual is \n        first enrolled under a prescription drug plan under this part \n        (or an MA-PD plan under part D), is a full-benefit dual \n        eligible individual and is being provided medical assistance \n        for a covered part D drug under title XIX, qualified \n        prescription drug coverage must include coverage for such drug \n        unless a prescribing physician certifies that the coverage of \n        such drug is not medically necessary, regardless of whether the \n        individual subsequently remains a full-benefit dual eligible \n        individual.''.\n    (b) Effective Date.--The amendments made by subsection (a) shall be \neffective as if included in the enactment of Medicare Prescription \nDrug, Improvement, and Modernization Act of 2003 (Public Law 108-173).\n\nSEC. 2. MEDICARE PRESCRIPTION DRUG COVERAGE OF BENZODIAZEPINES.\n\n    (a) In General.--Section 1860D-2(e)(2)(A) of the Social Security \nAct (42 U.S.C. 1395w-112(e)(2)(A)) is amended by inserting after \n``agents)'' the following: ``and other than subparagraph (J) of such \nsection (relating to benzodiazepines)''.\n    (b) Effective Date.--The amendment made by subsection (a) shall be \neffective as if included in the enactment of Medicare Prescription \nDrug, Improvement, and Modernization Act of 2003 (Public Law 108-173).\n\nSEC. 3. PERMITTING STATE MEDICAID PROGRAMS TO COVER MEDICARE \n              PRESCRIPTION DRUG COPAYMENTS FOR FULL-BENEFIT DUAL \n              ELIGIBLE INDIVIDUALS.\n\n    (a) In General.--Section 1935(d) of the Social Security Act (42 \nU.S.C. 1396u-5(d)) is amended by adding at the end the following new \nparagraph:\n            ``(3) Optional coverage of medicare prescription drug cost-\n        sharing.--Notwithstanding paragraph (1), a State may, at its \n        option, provide medical assistance under the plan under this \n        title for the deductible and cost-sharing imposed under a \n        prescription drug plan (or an MA-PD plan) for full-benefit dual \n        eligible individuals and payment shall be available under \n        section 1903(a) with respect to such assistance provided. ''.\n    (b) Effective Date.--The amendment made by subsection (a) shall be \neffective as if included in the enactment of Medicare Prescription \nDrug, Improvement, and Modernization Act of 2003 (Public Law 108-173).\n\nSEC. 4. MEDICARE COVERAGE OF OFF-LABEL USES OF PRESCRIPTION DRUGS AND \n              BIOLOGICALS.\n\n    (a) In General.--Section 1860D--2(e) of the Social Security Act (42 \nU.S.C. 1395w-102(e)) is amended at the end by adding the following new \nparagraph:\n    ``(4) Rule of Construction.--Nothing in this subsection shall be \nconstrued as excluding from the definition of the term `covered part D \ndrug'--\n            ``(A) a drug described in paragraph (1)(A) on the sole \n        basis that such drug is prescribed by a physician for a use \n        other than a use included in the labeling of such drug pursuant \n        to the approval of the safety and effectiveness of such drug as \n        a prescription drug under section 505 or 507 of the Federal \n        Food, Drug, and Cosmetic Act or approval of such drug under \n        section 505(j) of such Act; or\n            ``(B) a biological product described in paragraph (1)(B) on \n        the sole basis that such product is prescribed by a physician \n        for a use other than a use included in the labeling of such \n        product pursuant to the licensure of such product under section \n        351 of the Public Health Service Act;\neven if the unlabeled use of the drug or product is not included in a \nstandard clinical reference compendia used by clinicians for purposes \nof providing guidance to such clinicians with respect to unlabeled uses \nof such a drug or product.''.\n    (b) Effective Date.--The amendment made by subsection (a) shall be \neffective as if included in the enactment of Medicare Prescription \nDrug, Improvement, and Modernization Act of 2003 (Public Law 108-173).\n\nSEC. 5. AUTHORIZATION FOR SECRETARY OF HEALTH AND HUMAN SERVICES TO \n              WAIVE DENIAL OF PRESCRIPTION DRUG COVERAGE.\n\n    (a) In General.--Section 1860D-4(h) of the Social Security Act (42 \nU.S.C. 1395w-104(h)) is amended at the end by adding the following new \nparagraph:\n    ``(4) Authorization for Secretary to Waive Denial of Prescription \nDrug Coverage.--After a part D eligible individual has exhausted all \nrights of such individual under this subsection and subsection (g), \nwith respect to a determination made under this subsection or \nsubsection (g) for a prescription drug plan not to provide for coverage \nof a covered part D drug (or a determination related to the application \nof tiered cost-sharing described in subsection (g)(2)), the individual \nmay apply to the Secretary for a waiver that requires the prescription \ndrug plan to provide for such coverage (or provide for an exception to \nthe structure of such tiered cost-sharing). Upon receipt of such \napplication, the Secretary may grant such waiver if the prescribing \nphysician certifies that the coverage of such prescription drug is \nmedically necessary with respect to the individual.''.\n    (b) Effective Date.--The amendment made by subsection (a) shall be \neffective as if included in the enactment of Medicare Prescription \nDrug, Improvement, and Modernization Act of 2003 (Public Law 108-173).\n\nSEC. 6. HOLDING PHARMACIES HARMLESS FOR CERTAIN COSTS INCURRED DURING \n              IMPLEMENTATION OF MEDICARE PART D.\n\n    (a) In General.--The Secretary of Health and Human Services shall \nprovide for such payments to pharmacies as may be necessary to \nreimburse pharmacies fully for--\n            (1) transaction fees associated with any point-of-sale \n        facilitated identification and enrollment process established \n        by the Secretary to facilitate, at point of sale, the \n        identification of drug plan assignment of full-benefit dual \n        eligible individuals (as defined in section 1935(c)(6) of the \n        Social Security Act (42 U.S.C. 1396u-5(c)(6)) or the enrollment \n        of previously unidentified or new full-benefit dual eligible \n        individuals into Medicare prescription drug coverage under part \n        D of title XVIII of the Social Security Act;\n            (2) costs associated with technology or software upgrades \n        necessary to make any identification and enrollment inquiries \n        as part of a process described in paragraph (1); and\n            (3) costs of providing prescription drugs and biological \n        products to part D eligible individuals (as defined in section \n        1860D-1(a)(3)(A) of such Act (42 U.S.C. 1395w-101(a)(3)(A)) \n        whose prescription drug plans could not be identified, if the \n        pharmacy involved was not reimbursed for such costs upon \n        completion of plan reconciliation.\n    (b) Time.--Payments under subsection (a) shall be made with respect \nto fees and costs incurred during the period beginning on December 1, \n2005, and ending on June 1, 2006.\n    (c) Payments From Account.--Payments under subsection (a) shall be \nmade from the Medicare Prescription Drug Account under section 1860D-16 \nof the Social Security Act (42 U.S.C. 1395w-116) and shall be deemed to \nbe payments from such Account under subsection (b) of such section."
}